Detalles de la búsqueda
1.
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH).
Eur J Haematol
; 102(6): 465-471, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30828868
2.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267597
3.
Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy.
Leuk Lymphoma
; 57(1): 86-91, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-25860236
4.
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT.
Bone Marrow Transplant
; 55(2): 461-463, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30988379
Resultados
1 -
4
de 4
1
Próxima >
>>